TABLE 1.
Demographics, symptoms, and clinical findings for HIV-positive patients with disseminated M. genavense infection and disseminated MAC infection
| Characteristic | M. genavense(n = 12) | MAC (n = 24) |
|---|---|---|
| Sex (no. of patients) | ||
| Men | 9 | 22 |
| Women | 3 | 2 |
| Nationality (no. of Danes/no. of foreigners) | 11/1 | 22/2 |
| Age (yr [mean/median]) | 34.8/34.0 | 35.2/33.5 |
| Risk group (no. of patients) | ||
| Homosexual | 7 | 18 |
| Heterosexual | 2 | 5 |
| Injection drug abuse | 0 | 1 |
| Blood transfusion | 1 | 0 |
| Other or unknown | 2 | 0 |
| No. of patients with: | ||
| Antimycobacterial prophylaxis | 0 | 0 |
| Antiretroviral treatment | 7 | 11 |
| No. of patients with the following/total no.: | ||
| Fever | 9/12 | 20/22 |
| Weight loss | 9/12 | 16/21 |
| Anorexia | 7/12 | 10/19 |
| Lymphadenopathy | 6/12 | 5/18 |
| Anemia | 8/12 | 11/24 |
| Pancytopenia | 6/10 | 11/24 |
| Abdominal paina | 6/10 | 1/24 |
| Diarrhea | 5/12 | 6/24 |
| Splenomegaly | 5/12 | 8/24 |
| Hepatomegaly | 3/12 | 5/24 |
| Mean CD4+ count (106/liter) | 18b | 15c |
| Mean survival time (wk) | 36d | 34c |
a
Significant (P = 0.003).
b
n = 11.
c
n = 24.
d
n = 12.